2028 Live Cell Imaging Market: Research Analysis, Application, Overview And Forecast

Comments · 146 Views

2028 Live Cell Imaging Market: Research Analysis, Application, Overview And Forecast

The global live cell imaging market is projected to reach USD 4.3 billion by 2028 from USD 2.7 billion in 2023, at a CAGR of 10.2% during the forecast period of 2023 to 2028. The growth of this market is majorly driven by growing adoption of high-content screening techniques in drug discovery. Live cell imaging is an essential tool in high-content screening (HCS), allowing researchers to observe and track cellular responses in real-time.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=163914483

The cell biology segment accounted for the largest share, by application in the live cell imaging market.

By application, the global live cell imaging market has been further categorized as cell biology, stem cells, developmental biology, and drug discovery. The cell biology segment held the largest share of the global live cell imaging market. This can be attributed to the increasing research activities in cell biology.

Key Market Players

The global market is a consolidated market, with Danaher (US), ZEISS Group (Germany), Thermo Fisher Scientific, Inc. (US), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), and  Sartorius AG (Germany) together accounting for ~75–85% of the global market.

Danaher (US)

Danaher designs, manufactures, and markets professional, medical, industrial, and commercial products and services. Its business consists of four segments: Biotechnology, Life Sciences, Diagnostics, and Environmental Applied Solutions. The Life Sciences business offers a broad range of research tools and provides solutions for five key subsegments: Flow Cytometry, Genomics, Lab Automation, Centrifugation, Particle Counting and Characterization, Mass Spectrometry, Microscopy, Industrial Filtration, and Genomic Consumables.

ZEISS Group (Germany)

ZEISS Group operates in the fields of optics and optoelectronics. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company operates its business through five segments: Semiconductor Manufacturing Technology, Industrial Quality and Research, Medical Technology, Consumer Markets, and Others. The Industrial Quality and Research segment provides industrial quality solutions and research microscopy solutions.

Sartorius AG (Germany)

Sartorius AG is an international pharmaceutical and laboratory equipment supplier. The company has two primary business segments: Bioprocess Solutions and Lab Products Services. The Lab Products Services division offers laboratory balances, pipettes, and laboratory consumables, among others. Live cell imaging products are offered mainly by the Lab Products Services division of the company.

Access Full Report along with TOC @ https://www.marketsandmarkets.com/Market-Reports/live-cell-imaging-market-163914483.html

The North America region catered the largest share of the live cell imaging market

The live cell imaging market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in live cell imaging, and collaborative initiatives contribute to the growth of the live cell imaging market in the North America region.

Recent Developments:

  • In February 2023, Nikon Corporation launched the Nikon Spatial Array Confocal (NSPARC) detector for AX systems. This detector enables high-resolution imaging of live tissue with minimal phototoxicity.
  • In January 2022, CytoSMART Technologies launched Omni Pro 12, adding to the Omni live cell imaging product portfolio.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=163914483

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Comments